Marta Cobo Marcos,Gregorio Romero-González,Julio Núñez
Marta Cobo Marcos
Editorial
Cardiorenal medicine. 2025 May 23:1-8. DOI:10.1159/000546349 2025
Nolan W Groninger,Drake E Dillman,Hunter Stafford et al.
Nolan W Groninger et al.
Cardiopulmonary exercise testing (CPET) is an emerging tool in nephrology that has garnished significant interest among clinicians and investigators. The power of CPET technology lies in its ability to accurately assess cardiovascular funct...
Ultrafiltration in Elderly Patients with Type 1 Cardiorenal Syndrome: Efficacy and Safety Outcomes [0.03%]
老年1型心肾综合征患者使用超滤的疗效和安全性分析：一项观察性研究
Lijuan Xu,Zhen Wang,Lei Sun et al.
Lijuan Xu et al.
Objective Due to the typical exclusion of very elderly patients from clinical trials, the applicability of trial results to this population with heart failure remains uncertain. Limited data exist regarding the efficacy and safety of ultraf...
POCUS Over Punchlines: Rethinking the Cardiology-Nephrology Standoff in the Era of MedEd Humor [0.03%]
笑谈超声 Pokecardiology 时代的肾脏病学与心脏病学教育幽默冲突的再思考
Abhilash Koratala,Eduardo R Argaiz,Rafael de la Espriella et al.
Abhilash Koratala et al.
Editorial
Cardiorenal medicine. 2025 May 16:1-8. DOI:10.1159/000546388 2025
Early Versus Late Acute Kidney Injury in Patients Undergoing Primary Percutaneous Coronary Intervention [0.03%]
早期与晚期急性肾损伤在行初次经皮冠状动脉介入治疗患者中的差异
Inbal Greenberg,Yacov Shacham,Maayan Konigstein et al.
Inbal Greenberg et al.
Introduction: Acute kidney injury (AKI) frequently complicates ST-elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI) and is associated with increased short- and lo...
The Cardiac and Renal Safety of Semaglutide in Patients with Type 2 Diabetes: A Real-World Study Based on FAERS [0.03%]
司美格鲁肽在2型糖尿病患者中的心脏和肾脏安全性：基于FAERS的真实世界研究
Jingyu Wang,Tong Xie,Yuemiao Zhang et al.
Jingyu Wang et al.
Background: Recently, a large clinical trial found that treatment with semaglutide significantly reduced the risk of renal damage and cardiovascular death in patients with type 2 diabetes (T2D). To validate these findings...
Secondary Cardiorenal Syndromes in Children: Focus on Type 3 to 5 Cardiorenal Syndrome [0.03%]
儿童继发性心肾综合征：着重探讨第3-5型心肾综合征
Emre Leventoğlu,Akif Kavgacı,Utku Arman Örün et al.
Emre Leventoğlu et al.
Background: The interaction between heart and kidneys involves a range of intricate mechanisms and biochemical pathways. This interaction manifests in a clinical state known as cardiorenal syndrome (CRS), which is charact...
Cardiorenal benefits of SGLT2 inhibitors in patients with chronic kidney disease and concomitant hypertension [0.03%]
慢性肾病合并高血压患者的钠葡萄糖共转运体2抑制剂的心肾获益
Mi Wang,Li Zuo
Mi Wang
Background: Uncontrolled hypertension is both a driver of chronic kidney disease (CKD), and a complication of the disease, as well as a risk factor for cardiovascular disease (CVD). Therefore, renal protective agents with...
Blood Pressure Variability in Older Patients with Chronic Kidney Disease [0.03%]
慢性肾脏病老年患者血压波动特点及其临床意义
Davi Wei Ming Wang,Bruna Cristine D Rodrigues,Maria Eugenia Canziani et al.
Davi Wei Ming Wang et al.
Introduction: An increased blood pressure variability (BPV) is associated with a high risk of cardiovascular events in the general population. This concept was scarcely tested in patients with chronic kidney disease. We i...
Estimating Glucose Disposal Rate and Its Association with All-Cause and Etiologically Specific Mortality in Cardiovascular-Kidney-Metabolic Syndrome Among U.S. Adults: Insights from NHANES 1999-2018 [0.03%]
在美国成人中估计心血管-肾脏-代谢综合征患者的葡萄糖处置率及其与全因和特异性病因死亡率的关联：1999-2018年NHANES数据启示
Xiaohan Ma,Sheng Chen,Jiang He
Xiaohan Ma
Background: The estimated glucose disposal rate (eGDR) is a useful indicator of insulin resistance (IR). This study explores its association with cardiovascular-kidney-metabolic syndrome (CKM), a relationship that has bee...